In the final hours of his administration, outgoing New Jersey Governor Phil Murphy signed into law a reconciled version of a psilocybin therapy pilot program punctuating a three-year legislative odyssey defined by bitter political infighting, allegations of “pharmaceutical gatekeeping,” and a high-stakes clash between national lobbying interests and local grassroots advocates. The signing on January […]